Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.
from Medical Xpress - latest medical and health news stories https://ift.tt/YrX7vge
Roche to pay $7.1 bn for Telavant Holdings
Posted by belhaouari bekhedda
Always On Time With Health News 24/7